ResearcherIndiana University HealthActive in the last 2 years
Alexandra M. Roch
Matched on ORCID iD 0000-0002-7835-3370; OpenAlex author ID A5063945104. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper
Papers 10
- Potential Health Disparities in the Early Detection and Prevention of Pancreatic Cancer. Co-author DOI 10.7759/cureus.60240↗
- Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? Co-author DOI 10.1002/jso.27289↗
- Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcomes in patients with pancreatic adenocarci… Co-author DOI 10.1016/j.surg.2022.06.046↗
- Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarcinoma: a multi-institutional analysis. Co-author DOI 10.1016/j.hpb.2019.12.012↗
- Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? Co-author DOI 10.1002/jso.25376↗
- Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma. First author DOI 10.1007/s11605-017-3513-z↗
- Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s11605-015-3005-y↗
- Extended distal pancreatectomy for pancreatic adenocarcinoma with splenic vein thrombosis and/or adjacent organ invasion. Co-author DOI 10.1016/j.amjsurg.2014.10.017↗
- Automated pancreatic cyst screening using natural language processing: a new tool in the early detection of pancreatic cancer. Co-author DOI 10.1111/hpb.12375↗
- Identification of Patients with Family History of Pancreatic Cancer--Investigation of an NLP System Portability. Co-author PMID 26262122↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eugene P. Ceppa · 7 shared papers, 2015–2023 · strength 0.76
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarc… DOI 10.1016/j.hpb.2019.12.012↗
- Michael Garrett House · 6 shared papers, 2015–2023 · strength 0.66
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? DOI 10.1002/jso.25376↗
- Nicholas Joseph Zyromski · 6 shared papers, 2015–2023 · strength 0.66
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? DOI 10.1002/jso.25376↗
- Rachel C. Kim · 3 shared papers, 2023–2024 · strength 0.60
- Paper Potential Health Disparities in the Early Detection and Prevention of Pancreatic Cancer. DOI 10.7759/cureus.60240↗
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Christopher M. Schmidt · 3 shared papers, 2019–2024 · strength 0.52
- Paper Potential Health Disparities in the Early Detection and Prevention of Pancreatic Cancer. DOI 10.7759/cureus.60240↗
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? DOI 10.1002/jso.25376↗
- Christian Max Schmidt · 6 shared papers, 2015–2023 · strength 0.47
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable … DOI 10.1007/s11605-017-3513-z↗
- Paper Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic… DOI 10.1007/s11605-015-3005-y↗
- Trang K. Nguyen · 2 shared papers, 2023 · strength 0.37
- Michele Yip-Schneider · 1 shared paper, 2024 · strength 0.23
- Rosalie A. Carr · 2 shared papers, 2017–2019 · strength 0.17
- Farzad Alemi · 1 shared paper, 2020 · strength 0.10
- Paul Hansen · 1 shared paper, 2020 · strength 0.10
- Adnan A. Alseidi · 1 shared paper, 2020 · strength 0.10
- Horacio J. Asbun · 1 shared paper, 2020 · strength 0.10
- Zeljka Jutric · 1 shared paper, 2020 · strength 0.10
- Susanne Gray Warner · 1 shared paper, 2020 · strength 0.10
- Saeed Mehrabi · 2 shared papers, 2015 · strength 0.10
- Hongfang Liu · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.